Bijoy  Sagar net worth and biography

Bijoy Sagar Biography and Net Worth

VP of Stryker

Bijoy Sagar became Vice President, Chief Digital Technology Officer on September 4, 2018.

Mr. Sagar is responsible for the development and execution of our digital strategy as well as our global information technology strategy. His function helps build digital services for our customers and solutions that enable excellent customer experience.

He joined Stryker as Vice President, Chief Information Officer in May 2014. Prior to joining us, Mr. Sagar spent 20 years in the medical technology industry, most recently serving as Chief Information Officer for Merck Millipore, and before that as Global Head of Information Systems and a member of the Divisional Board for the $15 billion Chemicals division of Merck KGaA. Prior to joining Merck in 2006, Bijoy held various roles of increasing responsibility with Millennium Pharmaceuticals, Amgen and Eli Lilly & Company.

Mr. Sagar holds bachelor’s and master’s degrees in science from the University of Bombay.

What is Bijoy Sagar's net worth?

The estimated net worth of Bijoy Sagar is at least $1.24 million as of May 6th, 2019. Mr. Sagar owns 3,350 shares of Stryker stock worth more than $1,242,113 as of December 25th. This net worth evaluation does not reflect any other investments that Mr. Sagar may own. Learn More about Bijoy Sagar's net worth.

How do I contact Bijoy Sagar?

The corporate mailing address for Mr. Sagar and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Bijoy Sagar's contact information.

Has Bijoy Sagar been buying or selling shares of Stryker?

Bijoy Sagar has not been actively trading shares of Stryker within the last three months. Most recently, Bijoy Sagar sold 2,000 shares of the business's stock in a transaction on Monday, May 6th. The shares were sold at an average price of $190.43, for a transaction totalling $380,860.00. Following the completion of the sale, the vice president now directly owns 3,350 shares of the company's stock, valued at $637,940.50. Learn More on Bijoy Sagar's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (Chair and CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 9 times. They sold a total of 489,490 shares worth more than $165,788,442.76. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.5% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Bijoy Sagar Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/6/2019Sell2,000$190.43$380,860.003,350View SEC Filing Icon  
12/7/2018Sell2,361$171.24$404,297.642,361View SEC Filing Icon  
See Full Table

Bijoy Sagar Buying and Selling Activity at Stryker

This chart shows Bijoy Sagar's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $370.78
Low: $366.56
High: $370.83

50 Day Range

MA: $374.80
Low: $352.82
High: $392.15

2 Week Range

Now: $370.78
Low: $292.43
High: $398.20

Volume

431,006 shs

Average Volume

1,267,093 shs

Market Capitalization

$141.35 billion

P/E Ratio

39.74

Dividend Yield

0.88%

Beta

0.94